(For a Reuters live blog on U.S., UK and European stock

markets, click or type LIVE/ in a news window.)

*

Futures up: Dow 0.03%, S&P 500 0.12%, Nasdaq 0.21%

Sept 9 (Reuters) - U.S. stock index futures were subdued

on Tuesday after the major indexes posted near-record closing

highs in the previous session and investors remained cautious

ahead of an impending employment rate revision.

A preliminary estimate of the nonfarm payrolls benchmark

published by the Bureau of Labor Statistics is due at 10 a.m.

ET, with economists predicting that the level of U.S. employment

for the 12 months through March could be slashed by as much as a

million jobs.

U.S. job numbers have given investors and the U.S. Federal

Reserve cause for concern, with nonfarm payroll data for July

and August confirming weakening labor market conditions.

The latest report has led traders to fully price in a

25-basis-point reduction in interest rates next week, while bets

also surfaced for a larger 50-bps trim, which stand at 11.8%,

according to CME's FedWatch tool.

At 05:22 a.m. ET, Dow E-minis rose 12 points, or

0.03%, S&P 500 E-minis gained 8 points, or 0.12%, and

Nasdaq 100 E-minis were up 50.25 points, or 0.21%.

Meanwhile, Nebius ( NBIS ) jumped 49% in premarket trading

after the AI infrastructure firm signed a $17.4-billion deal

with Microsoft ( MSFT ). Rival CoreWeave ( CRWV ) also gained,

adding 6.1%.

Inflation reports due this week will also be on investors'

radar to gauge the impact of President Donald Trump's tariff

policies on the U.S. economy, and whether a case could be made

for a bigger rate cut.

The three main indexes closed higher on Monday, with the

Nasdaq notching a record close, lifted by a rally in chip major

Broadcom ( AVGO ).

Wall Street has had a broadly positive start to September, a

month deemed historically bad for U.S. equities, with the

benchmark index losing 1.5% on average since 2000, data compiled

by LSEG showed.

In other stocks, U.S.-listed shares of Teck Resources

jumped 9.1% before the bell after the miner agreed to

merge with London-listed Anglo American on Tuesday.

Tourmaline Bio ( TRML ) jumped more than 56% after Swiss

pharma giant Novartis said it would acquire the

biopharmaceutical company for $1.4 billion.